These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
17. Modeling Treatment Response for Lamin A/C Related Dilated Cardiomyopathy in Human Induced Pluripotent Stem Cells. Lee YK; Lau YM; Cai ZJ; Lai WH; Wong LY; Tse HF; Ng KM; Siu CW J Am Heart Assoc; 2017 Jul; 6(8):. PubMed ID: 28754655 [TBL] [Abstract][Full Text] [Related]
18. Decreased WNT/β-catenin signalling contributes to the pathogenesis of dilated cardiomyopathy caused by mutations in the lamin a/C gene. Le Dour C; Macquart C; Sera F; Homma S; Bonne G; Morrow JP; Worman HJ; Muchir A Hum Mol Genet; 2017 Jan; 26(2):333-343. PubMed ID: 28069793 [TBL] [Abstract][Full Text] [Related]
19. Interrelation between α-Cardiac Actin Treadmilling and Myocardin-Related Transcription Factor-A Nuclear Shuttling in Cardiomyocytes. Gorey MA; Mericskay M; Li Z; Decaux JF Int J Mol Sci; 2022 Jul; 23(13):. PubMed ID: 35806398 [TBL] [Abstract][Full Text] [Related]
20. Elevated dual specificity protein phosphatase 4 in cardiomyopathy caused by lamin A/C gene mutation is primarily ERK1/2-dependent and its depletion improves cardiac function and survival. Choi JC; Wu W; Phillips E; Plevin R; Sera F; Homma S; Worman HJ Hum Mol Genet; 2018 Jul; 27(13):2290-2305. PubMed ID: 29668927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]